cyclin B2 Antibodies

Santa Cruz Biotechnology delivers a wide array of cyclin B2 monoclonal antibodies for research in cell cycle regulation and cancer biology. Cyclin B2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclin B2 plays a crucial role in the regulation of the cell cycle, particularly in the transition from the G2 phase to mitosis. The activation of cyclin-dependent kinase 1 (CDK1) requires cyclin B2, which drives the cell into mitosis, making it a key player in cell proliferation and division. Dysregulation of cyclin B2 has been implicated in various cancers, highlighting its significance as a potential biomarker and therapeutic target. Research has shown that cyclin B2 expression levels correlate with tumor progression in several cancer types. Understanding cyclin B2's function and regulation can provide valuable insights into cell cycle control mechanisms. Monitoring cyclin B2 activity helps researchers explore new therapeutic strategies for cancer treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cell cycle regulation and its impact on human health.